A study looking at dabrafenib and trametinib for non small cell lung cancer

This study looked at 2 drugs called dabrafenib and trametinib for non small cell lung cancer. It was for people whose cancer had spread elsewhere in the body. This is advanced non small cell lung cancer.

The study was open for people to join between 2012 and 2015. The team published some results in 2017. They published the final results in 2022.